1Assistant Professor, Kamineni Institute of Medical Sciences
2Assistant Professor, Mandya Institute of Medical Sciences, Mandya, Karnataka
3Professor & HOD, Kamineni Institute of Medical Sciences
4Associate Professor & HOD, Dept. of Pathology, ESIC Medical College, Sanathnagar, Hyderabad
Kumar Parepali5
*Corresponding Author: Email: dr_saritha14@yahoo.co.in
Online published on 14 October, 2017.
Cervical cancer has always been a growing concern in developing countries like India. Prevent ability at pre malignant/pre invasive stages has yearned the need for studying screening methods in detail. This study recapitulates the importance of PAP smear as affordable, sensitive screening method and need for repetitive and continuous testing in preventing invasive cancer.
The prospective study spanning for a year (July 2015 to June 2016) consisted of 1990 patients who presented with various gynecological symptoms. All patients were screened by cervical smear stained with PAP stain. Evaluation of the smears carried out by cytopathologist as per The 2001 Bethesda reporting system.
1990 patients study showed inflammatory lesion 1164 (58.49%), metaplasia 46 (2.31%), LSIL 10(0.50), HSIL 4(0.20%), SCC 12(0.60%), ASCUS 72 (3.62%), AGUS 2 (0.1%), atrophy 52(2.61%), inadequate for evaluation 238(11.97%) and 390(19.6%) didn't show any significant pathology. Majority of the patients in our study had non neoplastic inflammatory lesions. Neoplastic lesions (premalignant and malignant) were observed in 100 (5.02%) patients and were seen in 41–70 years age group.
The cervical neoplasia is common in 41–70 years, and they can be subjected to repeated Pap screening program to detect the early lesions (dysplasia) and treated appropriately to prevent cervical cancer.
Cervical Neoplasia, Screening, Cervical Pap smear, The Bethesda system
